HuR is involved in tumor-associated lymphangiogenesis through post-transcriptional mechanisms, potentially mediating lymphangiogenesis in the TME by influencing the expression of growth factor ligands and receptors, such as insulin-like growth factors 1 and 2 (IGF-1 and IGF-2) (168). The gene discussed is IGF1; the disease is neoplasm.